Logo image of RXII

Rxi Pharmaceuticals (RXII) Stock Analyst Ratings

NASDAQ:RXII - Nasdaq -

0.33  0 (0%)

After market: 0.33 0 (0%)

No Analyst data available for RXII.


Related screens